## TDG: Transdigm Group Incorporated - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -3.7% below STRENGTH zone (4.0-10.0%); PEG 3.20 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1237.71)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. 1,265 Shares in Transdigm Group Incorporated $TDG Purchased by BNP Paribas**
- Source: MarketBeat | 20251212T120809 | Somewhat-Bullish | Relevance: 100%
- BNP Paribas purchased a new stake of 1,265 shares in Transdigm Group Incorporated (NYSE:TDG) during the second quarter, valued at approximately $1.91 million. This comes amid significant institutional buying, with Vanguard and other firms increasing their holdings, resulting in institutional investors owning 95.78% of the company. However, the company has also seen heavy insider selling, including by the COO and a director, totaling 149,147 shares worth around $199.3 million in the last three months.

**2. Responsive Playbooks and the TDG Inflection**
- Source: Stock Traders Daily | 20251212T064600 | Neutral | Relevance: 100%
- This article discusses key findings for Transdigm Group Incorporated (NYSE: TDG), highlighting a mid-channel oscillation pattern and a significant 25.9:1 risk-reward setup. It outlines three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with a multi-timeframe signal analysis, all generated by AI models. The analysis also points to weak near-term sentiment that could lead to bearish positioning.

**3. Transdigm Group Incorporated $TDG is Hudson Way Capital Management LLC's 5th Largest Position**
- Source: MarketBeat | 20251214T130856 | Bullish | Relevance: 100%
- Hudson Way Capital Management LLC reduced its stake in Transdigm Group (TDG) by 7.6% in Q2, but it remains their fifth-largest holding, valued at approximately $96.63 million. Transdigm exceeded Q2 earnings and revenue expectations, and insiders have recently been net sellers of the stock. Analyst ratings for TDG are largely positive, with a consensus of "Moderate Buy."

**4. Holocene Advisors LP Acquires 22,390 Shares of Transdigm Group Incorporated $TDG**
- Source: MarketBeat | 20251214T125153 | Somewhat-Bullish | Relevance: 100%
- Holocene Advisors LP increased its holdings in Transdigm Group Incorporated ($TDG) by 18.7% in Q2, acquiring 22,390 additional shares to own a total of 142,043 shares valued at approximately $216 million. Despite this, company insiders have been net sellers, with significant share sales by Director Kevin M. Stein and COO Joel Reiss in recent months. Transdigm exceeded quarterly earnings expectations and maintains a "Moderate Buy" consensus rating with a $1,576.29 target price from analysts.

**5. Transdigm Group Incorporated $TDG Shares Purchased by George Kaiser Family Foundation**
- Source: MarketBeat | 20251213T114743 | Somewhat-Bullish | Relevance: 100%
- George Kaiser Family Foundation significantly increased its stake in Transdigm Group Incorporated (NYSE:TDG) by 1,515.8% in the second quarter, making it their 9th biggest position. Other institutional investors also adjusted their holdings in the aerospace company. Various Wall Street analysts have weighed in on TDG, with a consensus target price of $1,576.29, despite recent insider selling by company executives.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | Morgan Stanley | $1660 | $1600 | +4% |
| 2025-11-14 | JP Morgan | $1435 | $1405 | +2% |
| 2025-11-13 | RBC Capital | $1400 | $1385 | +1% |
| 2025-11-13 | BMO Capital | $1500 | $1420 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | Morgan Stanley | main | Overweight |
| 2025-11-14 | JP Morgan | main | Neutral |
| 2025-11-13 | RBC Capital | main | Sector Perform |
| 2025-11-13 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 29 ($1.91M) |
| Sells | 12 ($106.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+1.8%)
- Capital Internationa: 11.5% (+4.1%)
- Blackrock Inc.: 7.4% (-1.6%)
- Capital World Invest: 7.0% (-0.8%)
- JPMORGAN CHASE & CO: 4.5% (+26.5%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.3% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $107M sold (12 transactions in 90 days).
3. Valuation risk: PEG 3.2x with declining EPS estimates leaves no margin for error.
4. Long-term trend broken: trading 6.5% below SMA200.

### Catalysts

- Analyst target momentum: 5 raises (avg +3%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 3.20 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROA 11%, margin 24%). Balance sheet: strong liquidity (3.2x), $1.8B free cash flow. Insider selling cluster ($107.0M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $73.0B |
| Beta | 0.92 |
| 52W Range | $1183.60 - $1623.83 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.20 |
| Forward P/E | 28.3 |
| Current P/E | 33.7 |
| YoY Growth | 19.1% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -1.4% to -3.7% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.7pp (needs >4.0% for momentum thesis). AM_20 at -3.3% indicates price below own 20MA trend. Underperforming sector by 5.9pp, stock-specific weakness. Below SMA200 (0.94x), long-term trend not supportive. MACD histogram bearish (-6.72), momentum weakening. RSI neutral at 41. Elevated volume (1.3x 20MA), institutional activity likely. OFD pattern: -FTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.67% (CS: 12) | Weak |
| RSI_14 | 40.9 | Neutral |
| MACD Histogram | -6.72 | Bearish |
| vs SMA20 | 0.967x | Below |
| vs SMA50 | 0.985x | Below |
| vs SMA200 | 0.935x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1294.65
- **Stop Loss:** $1237.71 (4.4% risk)
- **Target:** $1351.59 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 21
- **Position Value:** $27,187.65
- **Portfolio %:** 27.19%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-03 (Est: $8.00)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $10.05 | $10.82 | +7.6% |
| 2025Q2 | $9.90 | $9.60 | -3.0% |
| 2025Q1 | $8.95 | $9.11 | +1.8% |
| 2024Q4 | $7.74 | $7.83 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*